🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single center, single arm Phase I study to establish the safety a...
Status
Suspended
Location
Changhai Hospital
Start Date
2020-07-16
Trial ID
NCT04053062
Treatments Being Tested
The four purposes of this study are: 1) to examine the feasibility of combi...
Status
Completed
Location
Chang Gung University
Start Date
2015-07-15
Trial ID
NCT02527499
Atrial fibrillation (AF) is the most common arrhythmia (irregular heart rhy...
Status
Completed
Location
Oxford Univeristy Hospitals NHS Foundation Trust
Start Date
2022-04-18
Trial ID
NCT05298553
In this study, there are two treatment groups called Cohort 1 and Cohort 2....
Status
Recruiting
Location
Texas Children's Hospital
Start Date
2020-02-03
Trial ID
NCT04099797
Treatments Being Tested
This study will test the safety and blood levels of the antibody BNT351 in ...
Status
Recruiting
Location
Cook County Health
Start Date
2026-02-09
Trial ID
NCT07392372
The body has different ways of fighting infection and disease. No single wa...
Status
Withdrawn
Location
University of North Carolina Chapel Hill
Start Date
2011-10-03
Trial ID
NCT01316146
Treatments Being Tested
This is a single center, single arm Phase I study to establish the safety a...
Status
Active Not Recruiting
Location
University of Pennsylvania
Start Date
2017-03-08
Trial ID
NCT03089203
Treatments Being Tested
The goal of this clinical trial is to evaluate how accurately the CART-I pl...
Status
Completed
Location
Sky Labs
Start Date
2022-09-15
Trial ID
NCT05725148
Treatments Being Tested
The purpose of this study is to find the largest safe dose of i15.NKG2D.zet...
Status
Recruiting
Location
Texas Children's Hospital
Start Date
2026-07-15
Trial ID
NCT07211737
A phase I study to evaluate the safety, tolerance and pharmacokinetics of S...
Status
Enrolling By Invitation
Location
Chinese PLA General Hospital
Start Date
2023-12-26
Trial ID
NCT06616727
Treatments Being Tested